October 26, 2018Open Access

Intravenous Iron in Patients Undergoing Maintenance Hemodialysis

Key Points

Key points are not available for this paper at this time.

Abstract

Among patients undergoing hemodialysis, a high-dose intravenous iron regimen administered proactively was superior to a low-dose regimen administered reactively and resulted in lower doses of erythropoiesis-stimulating agent being administered. (Funded by Kidney Research UK; PIVOTAL EudraCT number, 2013-002267-25 .).

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Macdougall et al. (Fri,) studied this question.

synapsesocial.com/papers/69d8045d7392c8ce61bee61e https://doi.org/https://doi.org/10.1056/nejmoa1810742

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Semiparametric Regression for the Mean and Rate Functions of Recurrent Events2000 · 942 citations
2Effect of ferric carboxymaltose on hospitalization and mortality outcomes in chronic heart failure: A meta-analysis2017 · 16 citations
3Time-Dependent Associations between Iron and Mortality in Hemodialysis Patients2005 · 286 citations
4The Efficacy and Safety of Iron Supplementation in Patients With Heart Failure and Iron Deficiency: A Systematic Review and Meta-analysis2015 · 57 citations
5The Effects of Normal as Compared with Low Hematocrit Values in Patients with Cardiac Disease Who Are Receiving Hemodialysis and Epoetin1998 · 1,931 citations

Bookmark

View Full Paper